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DOI: http://dx.doi.org/10.1016/j.hemonc.2013.02.002BACKGROUND AND OBJECTIVES: Umbilical cord blood is an important source of stem cells. However,
isolating multipotent mesenchymal stromal cells (MSCs) from umbilical cord blood presents methodological
challenges. We compared the effectiveness of six approaches to improve the success rate of MSC isolation
and proliferation from umbilical cord blood.
METHODS: Thirty umbilical cord blood units underwent investigation. In 10 samples, MNCs from each sample
were divided into four groups to test the effect of negative immunodepletion (NI) alone (group A); NI plus basic
fibroblastic growth factor (bFGF) supplementation together (group B); bFGF supplementation alone (group C);
and culture with neither NI nor bFGF (group D). The cells of each group were isolated from 10 mL of umbilical
cord blood. For investigating the effect of sample volume (group E) and MesenCult Proliferation Kits (group F),
cells were isolated from 45 ± 2 ml. MSCs were identified on the basis of morphological, flow cytometric and
differentiation potential characteristics.
RESULTS: In groups of A–D, one week after the initial seeding, the cells showed a rounded appearance, and in
the fourth week, many of them died. MSCs outgrowth was seen in 40% of the samples from group F, and this
yield was further enhanced to 60% in cultures done with the MesenCult Proliferation Kit (group F). The fibro-
blast-like cells expanded rapidly and showed features of MSCs.
CONCLUSION: Sample volume was the parameter that showed the greatest influence on the isolation yield of
MSCs from umbilical cord blood. This could be further enhanced by adding the MesenCult Proliferation Kit.Multipotent mesenchymal stromal cells(MSCs), previously known as mesenchy-mal stem cells,1 are a group of multipotent
clonogenic cells originally found mainly in the bone
marrow. These cells play a major role in hematopoie-
sis as the supportive stroma for hematopoietic stem
cell growth and differentiation in vivo. They can be
derived from adipose tissue, dental pulp and umbilical
cord blood (UCB) in addition to bone marrow.
Their most notable characteristic is their capability
for multi-lineage differentiation into cells such as oste-
oblasts, adipocytes, chondrocytes, cardiomyocytes,
endothelial cells,2 hepatocytes,3 and myoblasts4
in vitro.Hematol Oncol Stem Cell Ther 6(1) First Quarter 2013 hemoncstem.edmgr.comTheir simple ex vivo expansion, immunomodula-
tory properties5 and good differentiation characteris-
tics make these cells interesting candidates for
clinical cell therapies, and their use in clinical trials
has been approved in many countries.2,6 However,
there are some limitations on their clinical use. As
an instance, it is well known that the proliferation
and differentiation capacities as well as the therapeutic
potential of MSC may decrease with age.7 Therefore
UCB, which has long been regarded as a source of
young hematopoietic progenitors suitable for trans-
plantation, was believed to be an easily accessible
source of young and highly proliferative MSCs.8
However, research soon raised questions about this1
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assumption. Some studies denied the presence of
MSC in UCB,9–11 whereas others have claimed that
under suitable conditions an isolation rate up to
60% can be achieved.7 Generally, an enrichment rate
of around 30% is the widely reported result in most
studies.12–18
The most important cause of the limited success of
MSC isolation is the low frequency of these cells in
UCB. Culture techniques have shown the presence
of only 1–2 MSC clones per 108 mononuclear cells
of UCB, whereas in fresh bone marrow, MSC may ac-
count for 1–100 per million nucleated cells.18,19 This
fact led Bieback et al. to propose sample volume (at
least 33 mL) as a critical parameter for the isolation
of these cells.7 In contrast, Rebelatto et al. reported
that sample volume did not have any inﬂuence on
the success rate of MSC isolation.17
Earlier research reported improvements in MSCs
isolation by negative immunodepletion (NI) of
CD3+, CD14+, CD19+, CD38+, CD66b+ and gly-
cophorin A+ cells with commercial kits.8 Some stud-
ies found that supplementation of the culture medium
with the powerful mitogen basic ﬁbroblastic growth
factor (bFGF) enhanced the proliferation, differentia-
tion and survival of stem cells.8,20 However, other at-
tempts with NI were unsuccessful.17 Bieback et al.
found that use of a specialized medium (such as Mes-
enCult Proliferation Kit, StemCell Technologies,
Vancouver, Canada) can improve the isolation rate
of MSC from UCB. They have also suggested that
UCB units should not be processed later than 15 h
after collection.7 Javed et al. noticed that MSCs were
rarely identiﬁed in 37–40 weeks of gestational age in
UCB but frequently isolated from 24 to 28 weeks ges-
tational aged UCB.21
The ﬁnal problem of working with UCB units is
the contamination of cultures with a population of
heterogeneous cells with cytoplasmic extensions and
occasionally multiple nuclei12,19 in 80–90% of culture
plates.7 These cells were primarily named as the
osteoclast-like cells (OLCs) by Erices et al.12
Due to controversies regarding the optimization of
culture conditions, as well as the high costs for some
kits and supplements, we designed the present study
to investigate the effectiveness of different culture
media supplementation in improving the proliferation
and isolation of MSC from UCB.METHODS
Collection of cord blood units
A total of 30 samples of umbilical cord blood were
collected after full term normal vaginal delivery. AfterHedelivery and during detachment of the placenta from
the uterus, blood was allowed to drain from the end
of the cord into 50 mL-tubes containing 500 lL
1 mM EDTA as the anticoagulant. Each sample con-
sisted of a mean of 47 ± 2 mL UCB, which was pro-
cessed no later than 8 h after collection.
Collection of bone marrow units
A volume of 2–3 mL of bone marrow, anticoagulated
with heparin, was obtained from patients who under-
went diagnostic bone marrow aspiration after in-
formed written consent. Cultures from samples with
normal results were included in this study.
Isolation and culture of MNC from UCB
We used six different culture methods. In 10 samples,
MNCs from each sample were divided into four
groups to test the effect of NI alone (group A); NI
plus bFGF supplementation together (group B);
bFGF supplementation alone (group C); and culture
with neither NI nor bFGF (group D as the control).
For culturing each of the groups A–D, a volume of
10 mL blood from the same UC unit was used. Neg-
ative immunodepletion of CD3+, CD14+, CD19+,
CD38+, CD66b+, and glycophorin A+ cells was done
with RosetteSep kits (StemCell Technologies, Van-
couver, Canada) according to the manufacturer’s
instructions. After that, blood was loaded on Lym-
phoSep (1.077 g/mL, Biosera, Ringmer, UK) and
centrifuged at 450 g for 25 min. Mononuclear cells
(MNC) were then isolated from the buffy coat layer.
In groups C and D, cells were isolated only by gradi-
ent density centrifugation with LymphoSep as in
groups A and B.
Isolated MNC from each group were plated in un-
coated T25 culture ﬂasks (Orange Scientiﬁc). Groups
B and C cells were seeded in a-MEM (Invitrogen)
supplemented with 20% FBS (Gibco), 10 ng/mL
bFGF (Invitrogen), 4 mM GlutaMAX (Invitrogen),
100 U/mL penicillin and 100 lg/mL streptomycin
(Invitrogen). Cells from groups A and D were cul-
tured in the same media without bFGF.
The other 20 samples were used to test the inﬂu-
ence of large sample volume (group E) and MesenCult
Proliferation Kit supplementation in large volumes
(group F). In groups E and F, all MNCs were used
in the experiment. Group F cells were cultured with
the MesenCult Proliferation Kit (StemCell Technol-
ogies, Vancouver, Canada) supplemented with 4 mM
GlutaMAX (Invitrogen), 1000 U penicillin and
1000 lg streptomycin (Invitrogen) according to the
manufacturer’s instructions, and group E cells were
cultured in a-MEM (Invitrogen) supplemented withmatol Oncol Stem Cell Ther 6(1) First Quarter 2013 hemoncstem.edmgr.com
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20% FBS (Gibco), 4 mM GlutaMAX (Invitrogen),
100 U/mlL penicillin and 100 lg/mL streptomycin
(Invitrogen).
All ﬂasks were incubated at 37 C in 95% humid-
iﬁed air containing 5% CO2. Media of all ﬂasks were
changed four days after the initial seeding and non-
adherent cells were removed by medium exchange.
Thereafter all media were changed twice a week until
the ﬂasks became 80% conﬂuent or until no cell out-
growth was noted after two months. Cell isolation and
expansion were recorded every other day.
Cells from ﬂasks that reached 80% conﬂuency were
harvested by 0.25% trypsin–EDTA (Invitrogen) and
were replated 1:3 in the expansion medium.
Isolation and culture of MNC from BM
The bone marrow (BM) was loaded on LymphoSep
(1.077 g/mL, Biosera, Ringmer, UK) and centrifuged
at 450g for 25 min. Mononuclear cells (MNC) were
then isolated from the buffy coat layer. Isolated
MNCs were plated in uncoated T25 culture ﬂasks
(Orange Scientiﬁc) in a-MEM (Invitrogen) supple-
mented with 10% FBS (Gibco), 4 mM GlutaMAX
(Invitrogen), 100 U/mL penicillin, and 100 lg/mL
streptomycin (Invitrogen).
Flow cytometry
To analyze cell surface antigen expression, cells from
the third passage were harvested by 0.25% trypsin–
EDTA. Trypsin was neutralized with medium con-
taining FBS, and the isolated cells were washed twice
with PBS. Then the cells were incubated for 30 min
in the dark with the following anti-human antibodies:
CD90-ﬂuorescein isothiocyanate (FITC), CD14-phy-
coerythrin (PE), CD34-FITC, CD166-PE, CD45-
FITC, CD44-FITC, CD105-PE (Serotec, UK), and
CD73-PE (Becton Dickinson, USA). Mouse IgG1-
PE and IgG2a-FITC (Serotec) were used as the
isotype controls. Cells were analyzed in a BD
FACS-Calibur instrument.
Osteogenic differentiation
For osteogenic differentiation, MSCs from the third
passage were harvested by 0.25% trypsin–EDTA.
The cells were cultured in NH-OsteoDiff
Medium (Miltenyi Biotec, Germany) at a density of
3 · 104 cells/mL in 2-chamber culture slides (Becton
Dickinson) for four weeks according to the manufac-
turer’s instructions, and the medium was changed
twice per week. To verify differentiation after
morphological changes were observed, the cells were
analyzed by alizarin red staining. Brieﬂy, the cells were
washed once with PBS and ﬁxed in methanol forHematol Oncol Stem Cell Ther 6(1) First Quarter 2013 hemoncstem.edmgr.com10 min. They were stained with the solution of
0.1 M alizarin red (Sigma–Aldrich) in a 25% aqueous
solution of ammonia for 24 h, and then washed once
with distilled water.
Adipogenic differentiation
For adipogenic differentiation, cells from the third
passage were harvested as reported above and cultured
in MesenCult medium (StemCell Technologies) sup-
plemented with 10% Adipogenic Stimulatory Supple-
ments (StemCell Technologies) at a density of
1.5 · 104 cells/mL in 2-chamber culture slides
according to the manufacturer’s instructions. The cells
were cultured for three weeks and half of the medium
was changed each time the medium turned yellow.
After the cells showed appropriate morphological
changes, they were analyzed with Oil-red O staining.
Brieﬂy, the cells were ﬁxed in 4% formalin containing
1% calcium chloride for 1 h. The cells were then
stained with Oil-red O solution for 10–15 min and
counterstained with 70% ethanol for 1 min, and
washed with distilled water. The solution was made
with 0.05 M powder (Sigma–Aldrich) in 99% iso-
propranol diluted 3:2 with distilled water.
Statistical analysis
The data were analyzed with SPSS statistical soft-
ware. Chi-squared tests were used to assess the signif-
icance of the difference between parameters. P < 0.05
was considered statistically signiﬁcant.
Ethical consideration
The UCB was collected after legal consent.RESULTS
Culture characteristics
With NI, approximately one third of the cells were
depleted in groups A and B. In groups C and D,
the cell population was heterogeneous in shape and
size. One week after the initial seeding, the cells in
all four groups showed a rounded shape. By the fourth
week, most of the cells were dead in all four groups
and no CFU-F units were noted.
Only one or two ﬁbroblast-like colonies were seen
in four out of 10 ﬂasks of group E cultures, apart from
a few rounded cells. These ﬁbroblast-like cells inter-
estingly formed homogenous colonies (Figure 1B) that
were conﬂuent within 15 days. The formations of
ﬁbroblast-like colonies were enhanced in group F
(Figure 1A), where six of 10 ﬂasks developed colonies
with the morphological appearance of mesenchymal
cells (Table 1).3
Figure 1. Cells one week after initial seeding in (A) group E, (B) group F and (C) bone marrow MNCs. Spindle shaped confluent fibroblast like cells noted one month after
initial seeding within the flasks from (D) group E, (E) group F and (F) bone marrow. Fat vacuoles stained by Oil red O 21 days after cells were cultured in adipogenic media in
(G) group E, (H) group F and (I) bone marrow MSCs. As it is seen UCB-MSCs form smaller vacuole than BM-MSCs. Osteoblasts stained with Alizarin red four weeks after
culturing in osteogenic media from (J) group E cells, (K) group F cells and (L) bone marrow MSCs.
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group F, oval/round or elongated cells with visible
borders were seen. Some cells showed cytoplasmic
extensions and occasional multiple nuclei. These cells
were considered as OLCs (Figure 2A). Interestingly,
OLCs could become conﬂuent within two months
(Figure 2B). These cells were detached hardly by tryp-
sin. After passaging and subculturing, they adhered
and proliferated again, although their proliferationHewas limited (Figure 2C). In ﬂasks where both MSCs
and OLCs were present, the OLCs were occasionally
surrounded by a monolayer of small spindle-shaped
mononuclear cells which were probably MSC (Figure
2D). Group F cultures more frequently contained
OLCs than cultures of group E (Table 2). We ob-
served OLCs in cultures that used sample volumes
of less than 45 mL, and NI was not able to eliminate
these cells (Figure 2A).matol Oncol Stem Cell Ther 6(1) First Quarter 2013 hemoncstem.edmgr.com
Table 1. Yield of stem cell isolation from umbilical cord blood under different cell culture conditions.
Culture group Variable UCB volume UCB unit Stem cell growth
A NI only 10 mL 10 0
B NI and bFGF supplementation 10 mL 10 0
C bFGF supplementation 10 mL 10 0
D Control(1) 10 mL 10 0
E Large sample volume 50 mL 10 6 of 10
F MesenCult Proliferation Kit 50 mL 10 4 of 10
Total 30 10 of 30
Abbreviations: UCB, umbilical cord blood; NI, negative immunodepletion; bFGF, basic fibroblast growth factor.
Figure 2. (A) An osteoclast like cell (OLC) in group B culture (B) Confluent OLCs in group E after two months. (C) OLCs 3 days after passage were large and spindle-shaped,
multinucleated, and showed cytoplasmic extensions, making them clearly distinguishable from mesenchymal stem cells. (D) A multinuclear OLC surrounded by spindle-
shaped cells.
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samples within 30 umbilical cord units (success rate:
33.3%). None was from groups A–D. The isolation
yield in group E was 40% which enhanced to 60% with
MesenCult Proliferation Kit administration (Table 1).
Two days after primary cultivation of BM-MNCs,
adherent spindle-shaped cells were detected (Figure
1C). Expanded cells showed homogenous morphology
and these ﬁbroblast-like cells formed homogenous col-
onies that conﬂuented within 20 days (Figure 1F).Hematol Oncol Stem Cell Ther 6(1) First Quarter 2013 hemoncstem.edmgr.comFlow cytometric analysis
Flow cytometric analysis of the cells harvested from
UCB-derived cultures showed that the cells were po-
sitive for mesenchymal markers such as CD73
(98.68 ± 1.24%), CD105 (97.66 ± 1.93%), CD44
(100%), CD166 (99.88 ± 0.1%) and CD90
(89.28 ± 10.31%); and negative for hematopoietic
antigens such as CD45 (1 ± 0.87%), CD34
(0.91 ± 0.62%) and CD14 (0.47 ± 0.21%)
(Figure 3).5
Table 2. Yield of osteoclast-like cell growth from umbilical cord blood under different cell culture conditions.
Culture group Variable OLC growth Mesenchymal growth Mixed growth of OLCs and MSCs
A NI only 1 of 10 0 of 10 0 of 10
B NI and bFGF supplementation 0 of 10 0 of 10 0 of 10
C bFGF supplementation 0 of 10 0 of 10 0 of 10
D Control(1) 0 of 10 0 of 10 0 of 10
E Large sample volume 5 of 10 6 of 10 4 of 10
F MesenCult Proliferation Kit 2 of 10 4 of 10 2 of 10
Total 8 of 30 10 of 30 6 of 30
Abbreviations: UCB, umbilical cord blood; NI, negative immunodepletion; bFGF, basic fibroblast growth factor.
Figure 3. Immune phenotype of umbilical cord blood-derived fibroblast-like colony-forming cells.
6
original research report PARAMETERS THAT INFLUENCE THE ISOLATIONDifferentiation assay
Adipogenic differentiation was documented by both
morphological and staining criteria. One week after
seeding in the adipogenic medium, the cells showed
small isolated vacuoles that increased in number and
size with time (Figure 1E). These vacuoles did not be-
come as large as vacuoles in bone marrow-derived
MSC cultures but all were stained by Oil red O
(Figure 1G–I).
The earliest evidence of MSC differentiation to
osteoblasts was matrix depositions around the
cells in the second week after seeding. Full differenti-
ation to osteoblasts lasted four weeks. Mineraliza-
tion was documented by alizarin red staining
(Figure 1J–L).HeStatistics
The yield difference between high volume sample and
low volume sample was signiﬁcant (P < 0.05) but the
statistic analysis between MesenCult group (group F)
and control 2 (group E) did not show any signiﬁcance
(P value > 0.05). P value of OLC growth between
MesenCult group (group F) and control 2 (group
E) was higher than 0.05.DISCUSSION
Mesenchymal stem cells are multipotent cells that can
generate adipogenic, osteogenic, chondrogenic, myo-
genic and even endothelial cell lineages.2,7 Because of
their potential, increasing interest is focusing on thematol Oncol Stem Cell Ther 6(1) First Quarter 2013 hemoncstem.edmgr.com
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isolation of MSC capable of differentiating into meso-
dermal lineages for transplantation and tissue engi-
neering. Cells isolated for cell therapy should fulﬁll
the criteria proposed by the International Society
for Cellular Therapy22 to be considered as MSCs.
One of the most important sources of both hematopoi-
etic and mesenchymal stem cells is UCB. However, the
success rates of MSC isolation and proliferation from
UCB are low. Some reports9–11 claim that MSC isola-
tion and expansion from UCB are unsuccessful, but
our results show that UCB CFU-Fs are true MSCs
and all our ﬁndings provide sufﬁcient data conﬁrming
the fact that UCB does contain MSCs.
Like Wagner et al., we faced the crucial problem of
the low number of MSC in UCB in comparison to
bone marrow, which makes their isolation difﬁcult.14
Researchers have managed to isolate these cells from
UCB, albeit with low success rates. From a total of
644 UCB units processed for MSC isolation in differ-
ent studies, only 167 outgrowths have been reported
(26% success rate).12–17 This ﬁgure is similar to our
success rate of 33.3%. These results show that further
improvements are needed in the isolation of UCB
MSC.
Our data showed that the RosetteSep commercial
kit did not affect the puriﬁcation of MSCs from
UCB. Our ﬁndings cannot be compared with the ﬁnd-
ings of Lee et al. regarding the inﬂuence of NI and
bFGF supplementation, since they did not mention
the sample volume from which they isolated MNC.8
In large volume samples NI may facilitate MSC isola-
tion. However, we do not recommend NI as it was
not effective in the present set of experiments. Rebe-
latto et al. also found this technique to have no effect
on MSC yield.17 Furthermore, NI signiﬁcantly in-
creases the costs of isolation.
We noticed that bFGF could not increase the iso-
lation rate of MSCs. Furthermore, previous reports
showed that bFGF can increase the expression of
HLA class I, thus reinforcing the immune reaction
in allogenic transplantation and decreasing the
engraftment of transplanted cells.20,23
While Rebelatto et al. claimed that sample volume
did not correlate with MSC isolation,17 others have
proposed that sample volume (at least 33 mL7 or
45 mL19) is a critical parameter. In groups E and F
we used a sample volume of 45 mL of UCB. We
found that sample volume was the most signiﬁcant
parameter in inﬂuencing the success rate of UCB
MSC isolation (P < 0.05). In addition, we found that
the success rate of MSC isolation from a large volume
of UCB units was increased by the MesenCult Prolif-
eration Kit as much as 60% (P < 0.05).Hematol Oncol Stem Cell Ther 6(1) First Quarter 2013 hemoncstem.edmgr.comWe encountered the problem of OLC presence as
other researchers did.7,12,19 Bieback et al. reported the
presence of monocytic cells that fused to form OLCs
in about 80–90% of their culture plates––a much
higher yield of OLC than we obtained.7 The differ-
ence between studies probably reﬂects differences in
the deﬁnition or description of these cells, which
would have led to different interpretations of the re-
sults of cell cultures. In this research, we considered
only cells with the same low proliferation capacity
and cytoplasmic extensions as OLC. The presence
of these cells in cultures is a signiﬁcant problem that
limits the use of UCB as a source of MSC for cell
therapy. Culture techniques appear unable to eradi-
cate them, and we found that even NI of CD3+,
CD14+, CD19+, CD38+, CD66b+, and glycophorin
A+ cells with the RosetteSep kit did not prevent their
appearance (Figure 3A). The ﬂow cytometric analysis
of OLC published by Erices et al. showed that com-
mon leukocyte antigen CD45 was uniformly
expressed on these cells.12 These authors found that
osteoclast-related antigen CD51/CD61 (vitronectin
receptor) was also seen on OLC, but only a few sub-
populations expressed the CD14 antigen. Because
CD14 is not uniformly present on OLC, the Rosette-
Sep kit used for NI cannot eradicate these cells.
We found that although the MesenCult Prolifera-
tion Kit enhanced UCB MSC isolation, this supple-
ment also supported the growth and adhesion of
OLC. The frequency of OLC in cultures supple-
mented with the MesenCult Proliferation Kit was
higher than other cultures but not statistically signif-
icant (P > 0.05).
The surface markers of UCB MSC in the present
study were similar to those identiﬁed on MSC derived
from bone marrow,17 i.e., CD73, CD90, CD105,
CD166 and CD44. In both studies, these cells
were negative for the hematopoietic cell antigens
CD14, CD34 and CD45. In contrast to the
report by Bieback et al.,7 CD105 (SH2) was
expressed by 97.66 ± 1.93% of our UCB-MSCs, a
proportion similar to that of bone marrow-derived
MSC.18
Our data contradict the ﬁndings of Kern et al. that
UCB-derived MSC cannot differentiate to adipose
tissue.15 We found that UCB-derived MSC differen-
tiated into adipose tissue after about 35 days of cul-
turing in an adipogenic medium. But in contrast to
bone marrow-derived MSC that developed large,
round lipid vacuoles, adipocyte differentiated UCB-
MSCs developed numerous small lipid vacuoles.
The same ﬁndings were noted by Rebelatto et al.13
and Karahuseyinoglu et al.247
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In general, our results showed that the number of
MSC in UCB is low in comparison to other common
sources; therefore further efforts are needed to im-
prove the success rate of isolation. We increased the
success rate of isolation up to 60% by using a larger
sample volume and applying the MesenCult Prolifer-
ation Kit. According to our data, the use of the
RosetteSep kit did not improve the isolation of these
scarce cells. We showed that UCB-derived MSC can
differentiate to adipose and osteogenic tissue, but this
requires longer culture periods in special media.
Obtaining pure MSCs from UCB is made difﬁcult
by the appearance of OLC in the cultures. We suggest
that CD45 depletion from UCB-MNCs containing atHeleast 108 cells may be an alternative for OLC-free iso-
lation of multipotent mesenchymal stromal cells from
umbilical cord blood.Acknowledgements
We gratefully acknowledge the collaboration of Stem Cell
lab of anatomy department. This work was supported by
the grant no.89-5180 of Shiraz University of Medical sci-
ences. The present study was done in fulﬁllment of
requirement of the MD degree defended by A. Vas-
aghi.The authors wish to thank K. Shashok (AuthorAID
in the Eastern Mediterranean) for improving the prepara-
tion of this manuscript, and M. Gholami at the Center
for Development of Clinical Research of Nemazee Hospi-
tal for research assistance.REFERENCES1. Horwitz EM, Le Blanc K, Dominici M, et al..
Clarification of the nomenclature for MSC: The
International Society for Cellular Therapy position
statement. Cytotherapy 2005;7(5):393–5.
2. Abdallah BM, Kassem. Human mesenchymal
stem cells: from basic biology to clinical applica-
tions. Gene Ther 2008;15(2):109–16.
3. Ayatollahi M, Salmani MK, Soleimani M, et al..
Expansion of human marrow derived mesenchymal
stem cells and their trans-differentiation potential.
Iran Red Crescent Med J 2010;12(4):446–52.
4. Baghaban Eslaminejad MR, Jahangir Sh, Aghd-
ami N. Comparison of proliferation, senescence and
differentiation into skeletal cell lineages of murine
bone marrow-derived and amniotic fluid mesenchy-
mal stem cells. Iran Red Crescent Med J
2010;12(6):615–23.
5. Ebrahimi M, Aghdami N. The applications of
bone marrow-derived stem cells to induce tolerance
and chimerism in organ transplantation. Int J Org
Transplant Med 2010;1(4):157–69.
6. Malekzadeh R, Mohamadnejad M, Alimoghad-
dam K, Bagheri M, Baharvand H, Ghavamzadeh A.
Cell-based regenerative therapy as an alternative to
liver transplantation for end-stage liver disease:
experience from Iran. Int J Org Transplant Med
2010;1(1):21–7.
7. Bieback K, Kern S, Klter H, Eichler H. Critical
parameters for the isolation of mesenchymal stem
cells from umbilical cord blood. Stem Cells
2004;22(4):625–34.
8. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL,
Chen TH. Isolation of multipotent mesenchymal stem
cells from umbilical cord blood. Blood
2004;103(5):1669–75.9. Mareschi K, Biasin E, Piacibello W, Aglietta M,
Madon E, Fagioli F. Isolation of human mesenchymal
stem cells: bone marrow versus umbilical cord
blood. Haematologica 2001;86(10):1099–100.
10. Wexler SA, Donaldson C, Denning-Kendall P,
Rice C, Bradley B, Hows JM. Adult bone marrow is a
rich source of human mesenchymal `stem' cells but
umbilical cord and mobilized adult blood are not. Br
J Haematol 2003;121(2):368–74.
11. Yu M, Xiao Z, Shen L, Li L. Mid-trimester fetal
blood-derived adherent cells share characteristics
similar to mesenchymal stem cells but full-term
umbilical cord blood does not. Br J Haematol
2004;124(5):666–75.
12. Erices A, Conget P, Minguell JJ. Mesenchymal
progenitor cells in human umbilical cord blood. Br J
Haematol 2000;109(1):235–42.
13. Yang SE, Ha CW, Jung M, et al.. Mesenchymal
stem/progenitor cells developed in cultures from UC
blood. Cytotherapy 2004;6(5):476–86.
14. Wagner W, Wein F, Seckinger A, et al..
Comparative characteristics of mesenchymal stem
cells from human bone marrow, adipose tissue, and
umbilical cord blood. Exp Hematol
2005;33(11):1402–16.
15. Kern S, Eichler H, Stoeve J, Klter H, Bieback K.
Comparative analysis of mesenchymal stem cells
from bone marrow, umbilical cord blood, or adipose
tissue. Stem Cells 2006;24(5):1294–301.
16. Manca MF, Zwart I, Beo J, et al.. Character-
ization of mesenchymal stromal cells derived from
full-term umbilical cord blood. Cytotherapy
2008;10(1):54–68.
17. Rebelatto CK, Aguiar AM, Moret¼o MP, et al..
Dissimilar differentiation of mesenchymal stem cellsmatol Oncol Stem Cell Therfrom bone marrow, umbilical cord blood, and
adipose tissue. Exp Biol Med 2008;233(7):901–13.
18. Martins AA, Paiva A, Morgado JM, Gomes A,
Pais ML. Quantification and immunophenotypic
characterization of bone marrow and umbilical cord
blood mesenchymal stem cells by multicolor flow
cytometry. Transplant Proc 2009;41(3):943–6.
19. Musina RA, Bekchanova ES, Belyavskii AV,
Grinenko TS, Sukhikh GT. Umbilical cord blood
mesenchymal stem cells. Bull Exp Biol Med
2007;143(1):127–31.
20. Sotiropoulou PA, Perez SA, Salagianni M,
Baxevanis CN, Papamichail M. Characterization of
the optimal culture conditions for clinical scale
production of human mesenchymal stem cells. Stem
Cells 2006;24(2):462–71.
21. Javed MJ, Mead LE, Prater D, et al.. Endothe-
lial colony forming cells and mesenchymal stem cells
are enriched at different gestational ages in human
umbilical cord blood. Pediatr Res 2008;64(1):68–73.
22. Dominici M, Le Blanc K, Mueller I, et al..
Minimal criteria for defining multipotent mesenchy-
mal stromal cells. The International Society for
Cellular Therapy position statement. Cytotherapy
2006;8(4):315–7.
23. Kang XQ, Zang WJ, Bao LJ, et al.. Fibroblast
growth factor-4 and hepatocyte growth factor
induce differentiation of human umbilical cord
blood-derived mesenchymal stem cells into hepato-
cytes. World J Gastroenterol 2005;11(47):7461–5.
24. Karahuseyinoglu S, Cinar O, Kilic E, et al..
Biology of stem cells in human umbilical cord
stroma: in situ and in vitro surveys. Stem Cells
2007;25(2):319–31.6(1) First Quarter 2013 hemoncstem.edmgr.com
